The Journal of Neuroscience, July 14, 2004, 24(28):6343-6351; doi:10.1523/JNEUROSCI.0563-04.2004
Previous Article | Next Article 
Cellular/Molecular
Variability in the Benzodiazepine Response of Serotonin 5-HT1A Receptor Null Mice Displaying Anxiety-Like Phenotype: Evidence for Genetic Modifiers in the 5-HT-Mediated Regulation of GABAA Receptors
Sarah J. Bailey and
Miklos Toth
Department of Pharmacology, Weill Medical College of Cornell University, New York, New York 10021
Benzodiazepines (BZs) acting as modulators of GABAA receptors (GABAARs) are an important group of drugs for the treatment of anxiety disorders. However, a large inter-individual variation in BZ sensitivity occurs in the human population with some anxiety disorder patients exhibiting diminished sensitivity to BZ and reduced density of GABAARs. The mechanism underlying BZ treatment resistance is not known, and it is not possible to predict whether an anxiety patient will respond to BZ. 5-Hydroxytryptamine1A receptor (5-HT1AR) null mice (R-/-) on the Swiss-Webster (SW) background reproduce several features of BZ-resistant anxiety; they exhibit anxiety-related behaviors, do not respond to BZ, have reduced BZ binding, and have decreased expression of the major GABAAR subunits
1 and
2. Here, we show that R-/- mice on the C57Bl6 (B6) background also have anxiety phenotype, but they respond to BZ and have normal GABAAR subunit expression. This indicates that the 5-HT1AR-mediated regulation of GABAAR
subunit expression is subject to genetic modification. Hybrid SW/B6-R-/- mice also exhibit BZ-resistant anxiety, suggesting that SW mice carry a genetic modifier, which mediates the effect of the 5-HT1AR on the expression of GABAAR
subunits. In addition, we show that this genetic interaction in SW mice operates early in postnatal life to influence the expression of GABAAR
subunits at the transcriptional level. These data indicate that BZ-resistant anxiety results from a developmental arrest of GABAAR expression in SW-R-/- mice, and a similar mechanism may be responsible for the BZ insensitivity of some anxiety patients.
Key words: anxiety; benzodiazepine; GABA; serotonin; mouse; neurotransmitter
Received Nov 26, 2003;
revised May 28, 2004;
accepted May 31, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
S. J. Bailey, M. A. Ravier, and G. A. Rutter
Glucose-Dependent Regulation of {gamma}-Aminobutyric Acid (GABAA) Receptor Expression in Mouse Pancreatic Islet {alpha}-Cells
Diabetes,
February 1, 2007;
56(2):
320 - 327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-L. Liu, Y.-R. Lin, M.-H. Chan, and H.-H. Chen
Effects of Toluene Exposure during Brain Growth Spurt on GABAA Receptor-Mediated Functions in Juvenile Rats
Toxicol. Sci.,
February 1, 2007;
95(2):
443 - 451.
[Abstract]
[Full Text]
[PDF]
|
 |
|